Prognostic value of posttreatment neutrophil–lymphocyte ratio in head and neck squamous cell carcinoma treated by chemoradiotherapy

2017 ◽  
Vol 44 (2) ◽  
pp. 199-204 ◽  
Author(s):  
Do Young Kim ◽  
In Su Kim ◽  
Sang Gyu Park ◽  
Hyojeong Kim ◽  
Young Jin Choi ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Prognostic Value ◽  
Neck Squamous Cell Carcinoma ◽  
Neutrophil Lymphocyte Ratio ◽  
Lymphocyte Ratio

scholarly journals Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma

Head & Neck ◽  
2018 ◽  
Vol 40 (7) ◽  
pp. 1555-1564 ◽  
Author(s):  
Sulsal-Ul Haque ◽  
Liang Niu ◽  
Damaris Kuhnell ◽  
Jacob Hendershot ◽  
Jacek Biesiada ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Differential Expression ◽  
Squamous Cell ◽  
Prognostic Value ◽  
Neck Squamous Cell Carcinoma ◽  
Non Coding Rna ◽  
Long Non Coding Rna

PROGNOSTIC VALUE OF MX1 IN HEAD AND NECK SQUAMOUS CELL CARCINOMA

2017 ◽  
Vol 124 (3) ◽  
pp. e220
Author(s):  
C. DONNELLY ◽  
L. DONNELLY ◽  
Y. XIE ◽  
OKEMOS E. BELLILE ◽  
G. WOLF ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Prognostic Value ◽  
Neck Squamous Cell Carcinoma

Prognostic value of lymph node ratio in head and neck squamous cell carcinoma

Head & Neck ◽  
2018 ◽  
Vol 40 (5) ◽  
pp. 1082-1090 ◽  
Author(s):  
Yoav P. Talmi ◽  
Robert P. Takes ◽  
Eran E. Alon ◽  
Iain J. Nixon ◽  
Fernando López ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Lymph Node ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Prognostic Value ◽  
Lymph Node Ratio ◽  
Neck Squamous Cell Carcinoma ◽  
Node Ratio

Prognostic value of partial EMT‐related genes in head and neck squamous cell carcinoma by a bioinformatic analysis

Oral Diseases ◽  
2020 ◽  
Vol 26 (6) ◽  
pp. 1149-1156 ◽  
Author(s):  
Satoru Kisoda ◽  
Wenhua Shao ◽  
Natsumi Fujiwara ◽  
Yasuhiro Mouri ◽  
Takaaki Tsunematsu ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Prognostic Value ◽  
Bioinformatic Analysis ◽  
Neck Squamous Cell Carcinoma

scholarly journals The Prognostic Value of Toll-Like Receptors in Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis

2020 ◽  
Vol 21 (19) ◽  
pp. 7255
Author(s):  
Shrabon Hasnat ◽  
Roosa Hujanen ◽  
Bright I. Nwaru ◽  
Tuula Salo ◽  
Abdelhakim Salem
Keyword(s):  
Systematic Review ◽  
Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Head And Neck ◽  
Squamous Cell ◽  
Prognostic Value ◽  
Meta Analysis ◽  
Small Sample ◽  
Neck Squamous Cell Carcinoma ◽  
Toll Like Receptors

Head and neck squamous cell carcinoma (HNSCC) is a group of tumours which exhibit low 5 year survival rates. Thus, there is an urgent need to identify biomarkers that may improve the clinical utility of patients with HNSCC. Emerging studies support a role of toll-like receptors (TLRs) in carcinogenesis. Therefore, this systematic review and meta-analysis was performed to assess the prognostic value of TLR immunoexpression in HNSCC patients. We compiled the results of thirteen studies comprising 1825 patients, of which six studies were deemed qualified for quantitative synthesis. The higher immunoexpression of TLR-1 to 5 and 9 was associated with a worsening of the clinical parameters of patients with HNSCC. Furthermore, induced levels of TLR-3, 4, 5, 7 and 9 were found to predict the patients’ survival time. The meta-analysis revealed that TLR-7 overexpression is associated with a decreased mortality risk in HNSCC patients (HR 0.51; 95%CI 0.13–0.89; I2 34.6%), while a higher expression of TLR-5 predicted shorter, but non-significant, survival outcome. In conclusion, this review suggests that TLRs may represent some prognostic value for patients with HNSCC. However, due to small sample sizes and other inherent methodological limitations, more well designed studies across different populations are still needed before TLRs can be recommended as a reliable clinical risk-stratification tool.

Sign in / Sign up

Export Citation Format

Share Document